ReePrime

DEA marijuana rule changes could help medical research

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

DEA marijuana rule changes could help medical research

Healthweed

187 Views • Jun 11, 2017

Description

Many doctors are worried about pursuing research into the medical benefits of marijuana because only certain patients would be legally allowed to benefit from the research results. Less than half of states allow medical marijuana usage, and many have restrictions on the types of conditions that can get prescriptions. But if the DEA were to change its rules on medical marijuana, doctor's approach could change. The Drug Enforcement Administration is currently considering whether or not to lower marijuana's drug rating, which would ease some of the restrictions on studies around its medical use. Marijuana's medical benefits could be better understood if doctors were better able to set up trials for the drug.

Keywords & Tags

#Medical research #Entheogens #Weed #United States #medical cannabis industry #drugs #HealthWeed #cannabis #Drug Enforcement Administration #Medical Cannabis #medical marijuana #marijuana #Drug Control Law #Cannabis drug #Medical cannabis #Medical Research #Prohibition of drugs #CannabisDrug #U.S. Drug Enforcement Administration #pot #Marijuana #Euphoriants #cannabis drug #Psychiatry

More from User

Marijuana Laws At Risk with Proposed Trump Cabinet

Healthweed

Study Links Heavy Cannabis Use With Bone Disease

Healthweed

Brain Cancer Patients And Cannabis

Healthweed

Marijuana: The Positive And Negative Affects

Healthweed

Marijuana Use Among Pregnant Women Increasing

Healthweed

California Marijuana Dispensary's Provides Custom Guidance for Customers

Healthweed

Related Videos

Drug Enforcement Administration- Identifying Those Assisting Drug Dealers

hamzaflorida

Inside The DEA - Drug Enforcement Administration

Crime Watch

Spec Ops : Airborne Commando : Drug Enforcement Administration

JeuxVideo.com

Dismayed by Trump, Head of Drug Enforcement Administration to Leave

RisingWorld

Oversight of the Drug Enforcement Administration | House Oversight Congressional Hearing 7/27/2023

US Congressional Hearings

President Trump's Drug Enforcement Administration Head Will Resign

IBTimes